- 12 January, 2025
Should I invest in Under Armour shares after better than expected first-quarter results?
Under Armour (NYSE: UAA) shares have weakened from their recent highs despite better than expected first-quarter results. The U.S. stock market is losing some ground
Dogecoin, the leading indicator for alt season?
Dogecoin (DOGE) has been the poster child of altcoins for a very long time, particularly as it’s been around since 2013, making it one of
Auction giant Sotheby’s to accept BTC and ETH as payment via Coinbase
Sotheby’s, one of the world’s oldest and biggest auction houses, has announced that it will be accepting major cryptocurrencies as a new payment method at
From nay to yay: JPMorgan’s path to crypto could shake up finance
JPMorgan Chase’s constant love-hate relationship with cryptocurrency has been a fascinating one to observe over the years, especially since the digital asset sector started exploding
Bill and Melinda Gates announce divorce: What’s next for the Gates fortune?
After 27 years of marriage, Bill and Melinda Gates said their marriage was irretrievably broken as they filed for divorce in King County in Washington
4 key takeaways from Pfizer’s Q1 earnings report
Pfizer Inc. (NYSE: PFE) reported its financial results for the fiscal first quarter on Tuesday that topped analysts’ estimates for earnings and revenue. On the
J. R. Willett launched the first ICO… but still has a day job
ICOs? He held the first one. Stablecoins? He dreamed of them by accident. Vitalik Buterin tried to get him on board to help launch Ethereum,
Ethereum price hits $3.5K record as Winklevoss exchange adds Dogecoin
Ether (ETH) hit $3,500 on May 4 as the star of this week’s altcoin rally battled Dogecoin (DOGE) for returns supremacy. ETH/USD 1-hour candle chart
Under Armour no longer expects to remain in loss in fiscal 2021
Under Armour Inc. (NYSE: UAA) published its earnings report for the fiscal first quarter on Tuesday that topped Wall Street estimates, despite the ongoing COVID-19
3 key takeaways from CVS Health’s Q1 earnings report
CVS Health Corp. (NYSE: CVS) said on Tuesday that its profit and sales came in better than expected in the fiscal first quarter as all